Cubist Systematic Strategies, LLC Organon & Co. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $1.61 Million - $2.3 Million	96,919 New	96,919 $1.68 Million
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $481,028 - $720,420	22,457 Added 482.43%	27,112 $637,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $2.54 Million - $3.11 Million	-108,818 Reduced 95.9%	4,655 $130,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $675,511 - $988,729	28,868 Added 34.12%	113,473 $2.66 Million
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $2.26 Million - $2.78 Million	71,478 Added 544.51%	84,605 $2.86 Million
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $399,717 - $516,678	13,127 New	13,127 $459,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $3.57 Million - $4.62 Million	-124,383 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $3.56 Million - $4.43 Million	124,383 New	124,383 $4.08 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.